MM21: Mastering Venture Capital in a Volatile Market: Insights from a Life Science Investor
Update: 2024-04-12
Description
Venture capital funding is drying up, but is this a crisis or an opportunity? Squire Servance, founder of Syridex Bio,, explains the "denominator problem," why savvy investors are targeting overlooked assets, and how his fund addresses health disparities.
Link to full episode
Join the Podcast Newsletter: Link
Comments